The Company
Our Expertise
Press Releases
Awards & Grants
Corporate Responsibility
Working at Debiopharm
Drug Development
At a glance
Pipeline
Products
Publications
Leadership Team
Debiopharm Innovation Fund
At a Glance
Approach
Portfolio
News
Team
Contact
Manufacturing, Research & Development
At a Glance
Technology pipeline
Leadership Team
Awards & Grants
Corporate Responsibility
Careers
Press Releases
Media
Manage cookies
Our parent company
Contact us
Share
Share
Home
Drug development
Publications
Debio 1143 Mode of Action: a B…
Debio 1143 Mode of Action: a Broad Chemo-Radio and Immuno-Therapy Sensitizer
September 24, 2019
